144 ·Filed Aug 20, 2026

NMRA

Neumora Therapeutics, Inc.
BEARISH
Impact 5/10
Horizondays Processed1mo ago SEC0001964306-26-000403
Form 144 — notice of proposed sale of securities
Actionable Insight ▼ Bearish

The director's repeated Form 144 filings over four consecutive days signal a deliberate monetization of equity awards. While the individual amounts are modest relative to market cap, the pattern warrants monitoring for further insider selling ahead of any upcoming catalysts or earnings. Traders should watch for additional Form 144 or Form 4 filings in the coming weeks.

DirectionBearish
Confidencemedium
Horizondays
Latest settled — T+20d
NMRA ▼ -57.56% at T+20d
SHORT call ✓ call won +57.56% · α vs SPY +57.03% · entry $1.63 → $0.6918
Next anchor: T+60d in 6w
Latest observation: T+28 +60.70% FF3 residual α
Entry anchored
Aug 20, 04:00 PM ET
via 1-min bar
T+1d
-6.44%
call +6.44% · α +6.15%
$1.53
settled 6w ago
T+5d
-14.72%
call +14.72% · α +15.20%
$1.39
settled 5w ago
T+20d
-57.56%
call +57.56% · α +57.03%
$0.6918
settled 14d ago
T+60d
—
call — · α —
—
in 6w

Price Chart

Loading chart...

Executive Summary

Director Daljit Singh Aurora filed a Form 144 notice to sell 134,452 shares (~$203,584) via a broker-assisted cashless exercise of employee stock options. This follows three prior sales by the same insider on Aug 17-19 totaling 277,773 shares (~$431,674), bringing the total proposed/executed sales to 412,225 shares (~$635,258) over four days. The selling is material relative to the company's $308M market cap and occurs amid a 20% historical win rate on prior NMRA reports, suggesting persistent insider monetization rather than a one-off event.

Key Facts

  • Director Daljit Singh Aurora filed Form 144 to sell 134,452 shares at ~$203,584 via cashless option exercise.
  • This follows three prior sales on Aug 17-19 totaling 277,773 shares (~$431,674).
  • Total insider sales over four days: 412,225 shares (~$635,258).
  • Company market cap is $308M; the proposed sale alone represents ~0.07% of shares outstanding.
  • The filing is an advance notice of intent to sell; the sale may not occur, but the pattern of consecutive filings is notable.

Financial Impact

Proposed sale of 134,452 shares valued at ~$203,584; cumulative insider sales over four days ~$635,258.

dilution

Risk Factors

  • Insider selling may indicate lack of confidence in near-term prospects.
  • Cashless exercise of options suggests the insider is not retaining shares, reducing alignment with shareholders.
  • Historical reports on NMRA show a 20% win rate at T+20, indicating the stock has been under persistent selling pressure.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
80% bullish (15 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 2 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001964306-26-000403
Document: 0001964306-26-000403.txt0001964306-26-000403
10 reports for NMRA
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+20▲ +52.85%Aug 17, 2026
Filters
Rows
Reports for NMRA — sortable, filterable
TypeNow
Aug 20, 2026
6w ago
144
BEARISH ★ 5/10
$1.63 $0.6918▲ +57.56%▲ +57.03%$0.4999 (+69.33%)
Aug 17, 2026
6w ago
144
BEARISH ★ 5/10
$1.64 $0.7732▲ +52.85%▲ +51.54%$0.4999 (+69.52%)
Aug 14, 2026
7w ago
8-K
NEUTRAL ★ 4/10
$1.60 $0.9994▼ −37.54%▼ −35.55%$0.4999 (−68.76%)
Aug 14, 2026
7w ago
Press Release
NEUTRAL ★ 4/10
$1.60 $0.9994▼ −37.54%▼ −35.55%$0.4999 (−68.76%)
Jul 27, 2026
9w ago
8-K
BULLISH ★ 5/10
$1.66 $1.53▼ −8.13%▼ −11.43%$0.4999 (−69.89%)
Jul 27, 2026
9w ago
Press Release
BULLISH ★ 7/10
$1.66 $1.53▼ −8.13%▼ −11.43%$0.4999 (−69.89%)
Jun 15, 2026
15w ago
8-K
BEARISH ★ 7/10
$0.9145 $1.60▼ −74.96%▼ −75.71%$0.4999 (+45.34%)
Apr 17, 2026
24w ago
DEFA14A
NEUTRAL ★ 2/10
$2.19 $1.77▼ −19.18%▼ −23.38%$0.4999 (−77.17%)
Mar 30, 2026
26w ago
Press Release
MIXED ★ 5/10
$1.93 $2.25▲ +16.58%▲ +3.98%$0.4999 (−74.10%)
Mar 16, 2026
28w ago
Press Release
NEUTRAL ★ 3/10
$2.87 $2.03▼ −29.27%▼ −33.05%$0.4999 (−82.58%)
Showing 10 of 10

US Market Status

Market Closed — Opens Mon (65h 8m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access